IRIS
LEPEDDA, Antonio Junior
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.820
AS - Asia 2.833
EU - Europa 1.875
SA - Sud America 1.556
AF - Africa 102
Continente sconosciuto - Info sul continente non disponibili 95
OC - Oceania 10
Totale 12.291
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.624
BR - Brasile 1.383
SG - Singapore 1.113
CN - Cina 848
IT - Italia 543
UA - Ucraina 530
HK - Hong Kong 270
VN - Vietnam 225
DE - Germania 214
FR - Francia 188
FI - Finlandia 92
GB - Regno Unito 91
CA - Canada 90
AR - Argentina 66
SE - Svezia 65
TR - Turchia 58
IQ - Iraq 49
IN - India 42
BD - Bangladesh 37
MX - Messico 36
ZA - Sudafrica 34
EC - Ecuador 33
RU - Federazione Russa 28
PK - Pakistan 26
UZ - Uzbekistan 23
MA - Marocco 21
KR - Corea 18
PL - Polonia 18
CO - Colombia 17
BE - Belgio 16
NL - Olanda 16
CR - Costa Rica 15
JP - Giappone 15
EU - Europa 13
GT - Guatemala 13
ID - Indonesia 13
VE - Venezuela 13
ES - Italia 12
KE - Kenya 12
CL - Cile 11
NP - Nepal 10
PE - Perù 10
PY - Paraguay 10
AU - Australia 9
DZ - Algeria 9
GR - Grecia 9
AE - Emirati Arabi Uniti 8
DK - Danimarca 8
IL - Israele 8
JM - Giamaica 8
PH - Filippine 8
TN - Tunisia 8
BO - Bolivia 7
HN - Honduras 7
AT - Austria 6
CZ - Repubblica Ceca 6
KZ - Kazakistan 6
UY - Uruguay 6
JO - Giordania 5
KG - Kirghizistan 5
LT - Lituania 5
MY - Malesia 5
SA - Arabia Saudita 5
AL - Albania 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
IR - Iran 4
NI - Nicaragua 4
TT - Trinidad e Tobago 4
AM - Armenia 3
AZ - Azerbaigian 3
BY - Bielorussia 3
EG - Egitto 3
MD - Moldavia 3
OM - Oman 3
PS - Palestinian Territory 3
SV - El Salvador 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
CG - Congo 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
HR - Croazia 2
KH - Cambogia 2
KW - Kuwait 2
LU - Lussemburgo 2
MF - Saint Martin 2
PA - Panama 2
PR - Porto Rico 2
RO - Romania 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
Totale 12.190
Salva come PNG Salva come JPEG
Città #
Dallas 1.469
Singapore 614
Chandler 559
Ashburn 378
San Jose 350
Jacksonville 323
Hong Kong 269
Council Bluffs 200
Beijing 178
Princeton 174
Santa Clara 163
New York 153
Nanjing 133
Sassari 123
Columbus 117
São Paulo 110
Lauterbourg 86
Ann Arbor 82
Wilmington 80
Ho Chi Minh City 78
Dearborn 69
Los Angeles 67
Milan 63
Nanchang 59
Shanghai 58
Rio de Janeiro 48
Hanoi 47
Boardman 45
Belo Horizonte 37
Tianjin 34
Changsha 32
Shenyang 32
Baghdad 30
Hebei 29
Woodbridge 29
Curitiba 27
Izmir 26
Campinas 24
Orem 23
Denver 21
Jiaxing 21
Johannesburg 21
Montreal 21
Tashkent 21
Porto Alegre 20
Phoenix 19
Toronto 19
Brasília 18
Buffalo 18
Seoul 18
Atlanta 17
Rome 17
San Francisco 17
Warsaw 17
Brussels 16
Kunming 16
Miano 16
Zhengzhou 16
Hangzhou 15
London 15
Mountain View 15
Cagliari 14
Da Nang 14
Salvador 14
Tokyo 14
Andover 13
Chicago 13
Goiânia 13
Guarulhos 13
Haiphong 13
Houston 13
Ningbo 13
Ribeirão Preto 13
Stockholm 13
Villiers-sur-marne 13
Frankfurt am Main 12
Guayaquil 12
Norwalk 12
Brooklyn 11
Dhaka 11
Florence 11
Fortaleza 11
Guatemala City 11
Jinan 11
Manaus 11
Manchester 11
Nairobi 11
Quito 11
San José 11
Bisceglie 10
Boston 10
Chennai 10
Guangzhou 10
Recife 10
Sorocaba 10
Amsterdam 9
Ankara 9
Bauru 9
Blumenau 9
Helsinki 9
Totale 7.260
Salva come PNG Salva come JPEG
Nome #
A novel LIF-CE method for the separation of hyaluronan- and chondroitin sulfate-derived disaccharides: Application to structural and quantitative analyses of human plasma low- and high-charged chondroitin sulfate isomers 253
Short-end injection capillary electrophoresis for quantification of plasma chondroitin sulfate isomer disaccharides 213
A proteomic approach to differentiate histologically classified stable and unstable plaques from human carotid arteries. IF 2009: 4.522 JCR: Q1 206
A poly-L-lactic acid/ collagen/glycosaminoglycan matrix for tissue engineering applications 202
Natural collagenic skeleton of marine sponges in pharmaceutics: Innovative biomaterial for topical drug delivery 196
Apolipoprotein Profiles in Atherosclerotic Disease 190
Identification of differentially expressed plasma proteins in atherosclerotic patients with type 2 diabetes 188
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 185
Apolipoprotein profiles in atherosclerotic disease 181
Association between human plasma chondroitin sulphate isomers and carotid atherosclerotic plaque 176
Molecular Characterization of Plasma HDL, LDL, and VLDL Lipids Cargos from Atherosclerotic Patients with Advanced Carotid Lesions: A Preliminary Report 169
Applications of two-dimensional electrophoresis technology to the study of atherosclerosis 169
Analysis of changes in tyrosine and serine phosphorylation of red cell membrane proteins induced by P. falciparum growth 168
Evaluation of Early Markers of Nephropathy in Patients with Type 2 Diabetes Mellitus 167
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-g (MIG) 166
Content and distribution of glycosaminoglycans/proteoglycans in human thoracic aortic aneurysm 163
A Method for Urinary Trypsin Inhibitor (UTI) Purification Combining Anion-Exchange Chromatography Enrichment and Preparative SDS-PAGE 162
Apolipoprotein Profiles in Atherosclerotic Disease 162
Gradients in pore size enhance the osteogenic differentiation of human mesenchymal stromal cells in three-dimensional scaffolds 158
Differential proteomic analysis of human atherosclerotic plaque extracts 157
Apolipoprotein profiles in atherosclerotic disease 154
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 150
Glycosaminoglycan and transforming growth factor beta 1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy 149
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 147
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoing carotid endarterectomy 144
A Collagen-GAG synthetic extracellular matrix entrapped into PLLA polymeric scaffolds. 144
A proteomic approach to identify circulating or tissue biomarkers of atherosclerosis 143
Glycosaminoglycan functionalization of electrospun scaffolds enhances Schwann cell activity 142
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 142
Levels of Urinary Trypsin Inhibitor and Structure of Its Chondroitin Sulphate Moiety in Type 1 and Type 2 Diabetes 140
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 140
Differential distribution of structural components and hydration in aortic and pulmonary heart valve conduits: Impact of detergent-based cell removal. IF 2010: 4.824 JCR: Q1 140
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-γ (MIG). 140
Development of a method for urine bikunin/urinary trypsin inhibitor (UTI) quantitation and structural characterization: Application to type 1 and type 2 diabetes 137
Impact of first trimester fasting glycemic levels on expression of proteoglycans in pregnancy 136
Marine-derived sulfated polysaccharides enhance hemocompatibility and endothelialization of nanofibrous PCL for vascular graft applications 133
Evaluation of plasma glycosaminoglycans levels and structure in patients undergoingcarotid endarterectomy 129
Apolipoprotein signature of hdl and ldl from atherosclerotic patients in relation with carotid plaque typology: A preliminary report 129
Proteomic analysis of plasma apolipoproteins in relation to atherosclerosis 127
Tuning Cell Differentiation into a 3D Scaffold Presenting a Pore Shape Gradient for Osteochondral Regeneration 127
Significance of urinary glycosaminoglycans/proteoglycans in the evaluation of type 1 and type 2 diabetes complications 124
Identification and characterization of biomarkers in atherosclerosis and diabetes. 123
Circulating Heparan Sulfate Proteoglycans as Biomarkers in Health and Disease 121
Plasma PP13, urinary GAGs/PGs as early markers of pre-eclampsia 121
QUANTITATIVE AND STRUCTURAL ANALYSES OF URINARY TRYPSIN INHIBITOR IN TYPE 1 AND TYPE 2 DIABETES 120
Deciphering Acute Coronary Syndromes Pathobiology Through Proteomics 119
Glycosaminoglycan and transforming growth factor beta1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy. IF 2009: 3.970 JCR: Q1 119
Urine bikunin as a marker of renal impairment in Fabry's disease 119
Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 119
Influencing chondrogenic differentiation of human mesenchymal stromal cells in scaffolds displaying a structural gradient in pore size 115
GAG content and distribution in porcine aortic valve tissue and in acellular pericardium scaffolds from three mammal species 114
Role of the small proteoglycan bikunin in human reproduction 112
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 111
Protein sulfhydryl-group oxidation in stable and unstable human carotid plaques 111
Protein oxidation in unstable plaque extracts from human carotid segments 110
Structural analisys of plasma glycosaminoglycans in patients with atheromatous lesions 110
Protein sulfhydryl group oxidation and mixed-disulfide modifications in stable and unstable human carotid plaques 109
Oxidative Modifications in Advanced Atherosclerotic Plaques: A Focus on In Situ Protein Sulfhydryl Group Oxidation 107
New Capillary Zone Electrophoresis (CZE) method for glycosaminoglycan analysis 105
Glycosaminoglycan content and distribution in human normal and varicose veins 104
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 103
Glycosaminoglycans: From Vascular Physiology to Tissue Engineering Applications 103
Protein sulfhydryl-groups oxidation in stable and unstable human carotid plaques 102
Urine Bikunin Quantitation and Structural Characterization in Type I and Type II Diabetes Patients 102
Effects of Acidic Polysaccharide-Enriched Extracts from Holothuria tubulosa on Two- and Three-Dimensional Invasive Breast Cancer Cell Models 101
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 101
Sequence variability of apolipoprotein E gene in Corsico-Sardinian ovines 100
Structural analysis of glycosaminoglycans and proteoglycans from fresh porcine aortic valves 100
Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles 98
Overview of Current Proteomic Approaches for Discovery of Vascular Biomarkers of Atherosclerosis 97
Glycosaminoglycan diversity in marine sponge extracellular matrix 97
Kidney post-transplant monitoring of urinary glycosaminoglycans/proteoglycans and monokine induced by IFN-ϒ (MIG) 97
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus 96
Morphological and biochemical traits of target marine sponges 96
Circulating Proteoglycans/Glycosaminoglycans as Cancer Biomarkers 96
GLYCOSAMINOGLYCAN DIVERSITY IN MARINE SPONGE EXTRACELLULAR MATRIX 95
Evidence for a pro-oxidant environment in atherosclerotic plaques from human carotid segments 93
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 92
Structural analysis of glycosaminoglycans from fresh and decellularized porcine aortic and pulmonary valves 92
Proteomic analysis of differential protein expression and post-translational modifications in human atherosclerotic plaques 91
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 90
Proteomic study of differential protein expression in stable and unstable human atherosclerotic plaque 88
Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium 88
Proteomic analysis of plasma-purified VLDL, LDL and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of Serum Amyloid A as a potential marker 88
Ultrasensitive Capillary Zone Electrophoresis (CZE) for glycosaminoglycan analisys in normal human plasma 87
Plasma Levels of C-Reactive Protein, Leptin and Glycosaminoglycans During Spontaneous Menstrual Cycle: Differences Between Ovulatory and Anovulatory Cycles 86
Glycosaminoglycans and fabry’s disease 86
Molecular and pathobiological insights of bikunin/UTI in cancer 85
Human serum albumin Cys34 oxidative modifications after infiltration in the carotid atherosclerotic plaque 85
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 84
Evaluation of human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 82
Structural analysis of glycosaminoglycans from fresh porcine aortic valves 80
Human serum albumin sulfhydryl groups oxidation in plasma and atherosclerotic plaque extracts 80
Human serum albumin Cys34 oxidative modifications following infiltration in the carotid atherosclerotic plaque 79
Structural analysis of plasma glycosaminoglycans in patients undergoing carotid endarterectomy 78
Searching for Atherosclerosis Biomarkers by Proteomics: A Focus on Lesion Pathogenesis and Vulnerability 77
Urine bikunin and kidney involvement in Fabry disease 59
Copolymers of Poly(Butylene Trans‐1,4‐Cyclohexanedicarboxylate)/Pripol as New Biomaterial Platform for Small Diameter Vascular Graft 40
Evolutionary History of the Adult β- Globin Gene in Wild Sheep: First Sequences From the Argali (Ovis ammon) and the Urial (Ovis vignei) 37
On the Anticoagulant Activities of Acidic Polysaccharides from the Western Mediterranean Sea Porifera 34
Totale 12.182
Salva come PNG Salva come JPEG
Categoria #
all - tutte 49.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.633
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022418 0 0 0 11 10 2 25 31 63 34 56 186
2022/2023996 94 82 10 185 112 157 0 122 163 13 40 18
2023/2024359 49 25 7 12 83 76 14 8 9 11 36 29
2024/20252.733 19 23 155 43 114 67 205 464 969 454 155 65
2025/20264.208 178 916 768 605 461 240 440 132 172 180 71 45
2026/20271.478 61 409 461 547 0 0 0 0 0 0 0 0
Totale 12.291